GlassScriptPhysician profile
Amanda Michelle Deering
NPI 1578296406
$635.52
in general payments reported to CMS, 2019-2025
12 companies · $17.35 in 2025
The $17.35 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $52.50 · 2024: $566 · 2025: $17.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $143.09 | 2024 | Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.27 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $89.94 | 2024 | |
| Merck Sharp & Dohme LLC | $60.48 | 2024-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $58.96 | 2023-2024 | Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $45.59 | 2024 | Xarelto |
| Esperion Therapeutics, INC. | $24.27 | 2024 | Nexletol |
| Pfizer INC. | $22.58 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.26 | 2024 | Lifevest |
| Mylan Specialty L.P. | $17.35 | 2023 | Yupelri |
| Kestra Medical Technology Services, INC. | $17.33 | 2024 | Assure Wcd |
| Amgen INC. | $15.40 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Deering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.